Relief Therapeutics Holding SA (SWX: RLF)
Switzerland
· Delayed Price · Currency is CHF
3.890
-0.470 (-10.78%)
Dec 3, 2024, 12:23 PM CET
RLF Employees
Relief Therapeutics Holding had 49 employees as of December 31, 2023. The number of employees decreased by 20 or -28.99% compared to the previous year.
Employees
49
Change (1Y)
-20
Growth (1Y)
-28.99%
Revenue / Employee
175.47K CHF
Profits / Employee
-943.65K CHF
Market Cap
47.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,605 |
Roche Holding AG | 103,605 |
Novartis AG | 76,057 |
Galderma Group AG | 6,545 |
Galenica AG | 7,902 |
SKAN Group AG | 1,527 |
Basilea Pharmaceutica AG | 147 |
DocMorris AG | 1,453 |
Relief Therapeutics Holding News
- 23 days ago - Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa - Accesswire
- 4 weeks ago - Relief Therapeutics signs letter of intent with Renexxion for reverse merger - Seeking Alpha
- 4 weeks ago - Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger - Accesswire
- 6 weeks ago - Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment - Accesswire
- 2 months ago - Relief Therapeutics gains on proof-of-concept data for antimicrobial agent - Seeking Alpha
- 2 months ago - Relief gains as experimental therapy performs on par with BioMarin’s Kuvan - Seeking Alpha
- 2 months ago - Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 - Accesswire
- 3 months ago - Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 - Accesswire